Aastrom Biosciences, Inc. (ASTM) Announces Closing of Public Offering of Common Stock and Warrants
8/16/2013 9:49:17 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ANN ARBOR, Mich., Aug. 16, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, announced today the closing of the previously announced underwritten public offering of 29,000,000 shares of its common stock, and warrants to purchase up to an aggregate of 29,000,000 shares of common stock, at a price to the public of $0.30 per share. The warrants have a per share exercise price of $0.375, are exercisable immediately, and expire five years from the date of issuance.
Help employers find you! Check out all the jobs and post your resume.
comments powered by